The Long COVID-19 Wearable Device Study

Launched by SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE · Feb 21, 2023

Keywords

ClinConnect Summary

The Long COVID-19 Wearable Device Study is a research project aiming to better understand and manage symptoms of Long COVID, Postural Orthostatic Tachycardia Syndrome (POTS), and related conditions. The study will involve participants who either already own a wearable device or will receive one for the duration of the trial. These devices track health data, which, along with educational materials, will help individuals learn how to manage their symptoms more effectively, especially after physical activity, which can sometimes make symptoms worse.

To be eligible for the study, participants must be at least 18 years old and have a diagnosis of Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), or POTS. They should be interested in using tools to manage their symptoms and must be willing to wear the device, share their data weekly, and complete surveys throughout the study. Importantly, there are no specific exclusions as long as participants meet the inclusion criteria. Overall, this study seeks to empower individuals with the tools and knowledge they need to take control of their health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Is at least 18 years old.
• * Has a self/and or physician diagnosis of:
• • Long COVID (based on the WHO working definition),
• • ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or
• • POTS (Postural Orthostatic Tachycardia Syndrome).
• • Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
• • Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one.
• • Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly.
• • Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback.
• • Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies.
• • Agrees to complete at least 75% of the study surveys.
• Exclusion Criteria:
• • As long as they meet inclusion there is no exclusion